Stericycle, Inc. (SRCL)
- Previous Close
44.73 - Open
44.69 - Bid 44.25 x 100
- Ask 44.31 x 100
- Day's Range
44.18 - 45.42 - 52 Week Range
37.78 - 57.06 - Volume
688,490 - Avg. Volume
498,734 - Market Cap (intraday)
4.11B - Beta (5Y Monthly) 1.09
- PE Ratio (TTM)
-- - EPS (TTM)
-0.21 - Earnings Date Jul 25, 2024 - Jul 29, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
62.25
Stericycle, Inc., together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions. It also provides secure information destruction services, including document, hard drive, destruction services under the Shred-it brand. The company serves healthcare businesses, including hospitals, health systems, non-affiliate hospitals, national and corporate healthcare, physician offices, surgery centers, veterinary and dental clinics, nursing and long-term care facilities, clinics and urgent care, dialysis centers, pharmacy, lab, research centers, home health organizations, etc.; and airports and seaports, education institutions, funeral homes and crematories, government and military, banks and professional services, and other businesses. Stericycle, Inc. was incorporated in 1989 and is headquartered in Bannockburn, Illinois.
www.stericycle.com13,095
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SRCL
Performance Overview: SRCL
Trailing total returns as of 5/1/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SRCL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SRCL
Valuation Measures
Market Cap
4.15B
Enterprise Value
6.05B
Trailing P/E
--
Forward P/E
19.46
PEG Ratio (5yr expected)
1.77
Price/Sales (ttm)
1.57
Price/Book (mrq)
1.65
Enterprise Value/Revenue
2.29
Enterprise Value/EBITDA
20.79
Financial Highlights
Profitability and Income Statement
Profit Margin
-0.74%
Return on Assets (ttm)
2.23%
Return on Equity (ttm)
-0.79%
Revenue (ttm)
2.64B
Net Income Avi to Common (ttm)
-19.5M
Diluted EPS (ttm)
-0.21
Balance Sheet and Cash Flow
Total Cash (mrq)
31M
Total Debt/Equity (mrq)
76.60%
Levered Free Cash Flow (ttm)
49.3M
Research Analysis: SRCL
Company Insights: SRCL
SRCL does not have Company Insights